Research in Clinical Dermatology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

STEM CELLS FOR AESTHETIC AND THERAPEUTIC USE

3rd WORLD DERMATOLOGY AND COSMETOLOGY CONGRESS
April 11-12, 2019 | Barcelona, Spain

Michael Lim Ming Soon

Prime Genesis Pte. Ltd, Singapore

Keynote : Res Clin Dermatol

Abstract:

What is Stem cell? The truth and the myth behind the stem cells therapy
What is Self-renewal and differentiation?
Types of Stem cells
Different Sources of stem cells
Functions of stem cells and understand the cellular processes
Characterization of MSC
Challenges and limitations of Stem cells therapy and possible solutions.
1. Selection of stem cells
2. Identify to culture or not to culture
3. Stem cells integration with host
4. Immunological rejection?
5. Autologous or Allogenic?
6. Pluripotency
7. To differentiate or not to differentiate
8. Secretomes, exosomes and trans differentiation
9. Will it stimulate cancer?
Why do it?
What is the aesthetic and therapeutic result that my teams have achieved?

Biography:

Michael Lim Ming Soon pioneered the 1st allogenic stem cell transplantation for the region of Asia Pacific since 2012 for aesthetic medicine and diseases intervention using cultured umbilical MSC and dental pulp MSC. He has done about 600 transplants ever since and is currently the pacesetter in the region for stem cells therapy. His experiences in the field of stem cells transplant have been amicable achieving many successes even in complicated terminal cases. He has been practicing in the field of Aesthetic medicine and Anti-Aging since the year 1999 and 2003 respectively. He has been training doctors ever since 2012 in USA, Australia, Germany, Malaysia, Singapore, Indonesia, Philippines, Taiwan and China. Currently, he is the founder of Prime Genesis Pte. Ltd, Singapore and Cell Genesis Pte. Ltd. Singapore which have footprints in more than 9 countries.

E-mail: [email protected]

PDF HTML
Get the App